• Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Techn

  2026-06-20

  Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) is formulated to minimize protein degradation during extraction and analysis, especially in workflows sensitive to divalent cations or phosphorylation status. It is not suitable for experiments needing EDTA-mediated metalloprotease inhibition. Proper use is essential for preserving sample integrity in Western blot, Co-IP, and related assays.

• Baicalin Methyl Ester: Reliable Solutions for Intestinal Bar

  2026-06-19

  This article details how Baicalin methyl ester (SKU N2884) addresses key experimental challenges in intestinal barrier and inflammation assays. Drawing on peer-reviewed data, it guides biomedical researchers through best practices for protocol design, data interpretation, and product selection. Emphasis is placed on reproducibility, mechanistic clarity, and the robust workflow advantages of sourcing from APExBIO.

• Acetylcysteine in 3D Tumor Microenvironment Research: Beyond

  2026-06-19

  Explore how Acetylcysteine empowers advanced tumor microenvironment modeling. Uncover new assay strategies for N-acetyl-L-cysteine in oxidative stress and stromal interaction studies.

• miR-24-3p/Sp1/PI3K Axis in Doxorubicin-Induced Heart Failure

  2026-06-18

  This study identifies miR-24-3p as a central upstream modulator of cardiac injury in doxorubicin-induced heart failure, acting via direct suppression of the Sp1/PI3K signaling pathway. Silencing miR-24-3p confers significant protection against apoptosis and oxidative stress, revealing a novel regulatory axis and potential therapeutic target for cardiac dysfunction.

• Sunitinib (SKU B1045): Precision RTK Inhibition in RCC Resea

  2026-06-18

  This article delivers a scenario-driven, evidence-backed workflow guide for deploying Sunitinib (SKU B1045) in cell viability, proliferation, and apoptosis assays, with a focus on renal cell carcinoma and multi-targeted RTK inhibition. Grounded in the latest literature and practical laboratory challenges, it outlines protocol parameters, troubleshooting strategies, and vendor selection, emphasizing the reliability and reproducibility of Sunitinib from APExBIO.

• BRD4770: G9a Histone Methyltransferase Inhibitor in Cancer R

  2026-06-17

  BRD4770, a selective G9a histone methyltransferase inhibitor from APExBIO, enables precise modulation of H3K9 methylation, unlocking new workflows for cancer biology and epigenetic regulation. Its robust performance in senescence induction and tumorigenesis studies delivers reproducible, targeted insights, especially in challenging models like PANC-1.

• Pharmacogenomics of Chloroquine/Hydroxychloroquine: Risks &

  2026-06-17

  The referenced systematic review synthesizes current evidence on how genetic variability in cytochrome P450 enzymes impacts the safety and efficacy of chloroquine and hydroxychloroquine. By mapping risk phenotypes, particularly in CYP2C8, CYP3A4/5, and CYP2D6, the paper highlights the clinical importance of pharmacogenomic assessment to optimize individualized therapy and minimize adverse outcomes.

• Anti-HMGB1 Rabbit Monoclonal Antibody: Research Protocol Gui

  2026-06-16

  The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) offers researchers a defined reagent for specific detection of HMGB1 in human, mouse, and rat samples via Western blot, immunohistochemistry, and flow cytometry. It is intended solely for scientific research and is not suitable for diagnostic or clinical use.

• PHF2 Regulates Inflammation in Alzheimer’s: Epigenetic Insig

  2026-06-16

  This study identifies the histone demethylase PHF2 as a key regulator of inflammatory gene expression in Alzheimer's disease, linking its upregulation to both neuroinflammation and cognitive deficits. By modulating PHF2, the authors demonstrate measurable reductions in neuroinflammatory markers and improvements in memory function, suggesting new epigenetic targets for neurodegenerative research.

• Pathogen-Derived Haem Regulates Phagocytosis and Virulence i

  2026-06-15

  A recent study reveals that Salmonella Typhimurium exploits methylation-driven upregulation of haem biosynthesis to suppress macrophage phagocytosis and enhance pathogen virulence. This mechanism provides new insight into host-pathogen interactions and suggests experimental strategies for dissecting heme metabolism in infection models.

• Losartan in Hypertension Research: Angiotensin II Receptor A

  2026-06-15

  Losartan is a benchmark angiotensin II receptor antagonist enabling precise dissection of cardiovascular and vascular cell signaling in both in vitro and in vivo settings. Explore how APExBIO’s Losartan supports advanced hypertension research, from optimized protocol parameters to troubleshooting complex experimental readouts.

• Mildronate-Derived Lipidoids Minimize Inflammation in mRNA D

  2026-06-14

  The reference study introduces mildronate-derived cationic lipidoids as a new class of lipid nanoparticle components that achieve effective mRNA vaccine delivery while significantly reducing inflammatory side effects in vivo. This advance offers a promising route for safer and more efficient mRNA-based immunotherapies, with broad implications for preclinical cancer vaccine research.

• Fenipentol in Pancreatic Secretion Research: Protocols & Ins

  2026-06-13

  Fenipentol (1-Phenyl-1-pentanol) is reshaping gastrointestinal and hepatobiliary research with its potent choleretic activity and safety profile. This article delivers practical workflows, troubleshooting strategies, and evidence-based advantages for employing Fenipentol in advanced experimental settings.

• Iron Stress Reprograms Enterocyte Metabolism and Inflammatio

  2026-06-12

  Navazesh and Ji (2025) demonstrate how iron deficiency and excess distinctly rewire enterocyte metabolism and modulate inflammatory gene expression using IPEC-J2 cells. Their findings clarify the metabolic vulnerabilities and adaptive responses of intestinal epithelial cells under iron imbalance, with implications for disease modeling and iron chelation research.

• Topological Stress Drives Persistent rDNA Damage and PML-Nuc

  2026-06-12

  This study reveals that topological stress—particularly through dual inhibition of topoisomerases and RNA polymerase I—induces persistent DNA double-strand breaks (DSBs) in ribosomal DNA, leading to the formation of PML-nucleolar associations (PNAs). The findings clarify how specific DNA damage responses in the nucleolus influence genome stability, senescence, and potentially tumorigenesis, with implications for the use of DNA damage inducers such as Aclarubicin in mechanistic cell biology research.

15796 records 1/1054 page Next 12345 下5页 Last page